Weekly Communique #34
3 December, 2020
WEEK IN REVIEW Updates to the living guideline New recommendations published this week cover: Dutasteride Oestrogen-containing therapies (including menopause hormone therapies (MHT) and contraceptives). These recommendations were developed by the Primary and Chronic Care Panel and the Pregnancy and Perinatal Care Panel with support from members of the Expert Advisory Group with specialist expertise in haematology, women's heath, reproductive health and family planning. Further details about these recommendations are...